Coherus Files On-Body Pegfilgrastim, Says ‘People Talk’ On Potential Rivals

Amgen’s Neulasta Onpro Device Continues To Hold More Than 40% Of Market

 
• By Dean Rudge
  
Frederic Muller/Shutterstock.com
Coherus launched Udenyca PFS in early 2019 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products